Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,194 total articles
Prologis (PLD) is a market-leading logistics REIT trading below its 50-day average with a 3%+ dividend yield, low leverage and steady free cash flow. The shares look attractive at $134.84 given a market cap near $129-131B, reasonable debt metrics (debt/equity ~0.68), and a business benefit from secular e-commerce and supply-chain reconfiguration. O…
Amprius Technologies makes some of the highest energy-density lithium-ion cells on the market using silicon nanowire anodes. That proprietary advantage matters most where weight and energy density directly translate into capability - military drones, advanced EV segments and aviation. The company still posts losses and negative free cash flow, so t…
Nano Labs (NA) is a speculative small-cap that combines an AI/chip pivot with heavy cryptocurrency exposure. H1 2026 results showed a 66% revenue collapse and a US$46.5m net loss driven largely by a RMB250.5m write-down tied to BNB fair value changes. With a market cap of roughly $52.7m, negative earnings, thin liquidity and mixed technicals, the s…
Journey Medical (DERM) is a commercial-stage dermatology company whose recent FDA-approved rosacea drug, Emrosi, could be the growth engine that re-rates the stock. At a $206M market cap and EV/Sales near 3.1x, the company already sells branded dermatology products and has a manageable balance sheet. This trade idea lays out a long trade with an en…
Saul Centers offers a compelling income entry at roughly $30.24 with a 7.8% current yield, conservative valuation metrics versus enterprise value, and an oversold technical setup. High leverage and retail exposure warrant caution, but steady dividends, concentrated suburban portfolio quality, and a large gap to the 52-week high create an asymmetric…
BlackBerry ($BB) looks positioned to surprise modestly to the upside when it reports Q2 on 09/24/2026. QNX's steady growth, improving commercial traction in automotive and embedded systems, plus a manageable balance sheet and $67.1M in free cash flow give the stock room to re-rate. We upgrade to a tactical buy with an entry at $8.00, stop at $6.50 …
Nano Labs is trading at a sub-$60M market cap after a brutal H1 2026. The company is pivoting from crypto-heavy losses toward AI hardware and AI-native infrastructure. This trade idea lays out a long bias with clear entry, stop and targets, driven by product launches, a North America AI data center MoU and an attractive valuation if execution impro…
Fabrinet (FN) has emerged as a core AI infrastructure supplier after data-center sales surpassed a $1B annualized run rate. Revenue and EPS are growing sharply, the balance sheet remains clean, and valuation on an EV/Sales basis is sensible relative to growth. This trade idea outlines a controlled long with entry at $380.00, stop at $350.00, and a …
Fabrinet is the go-to contract manufacturer for precision optical packaging and electro-mechanical assembly. Data center demand has shifted its revenue mix toward high-growth AI-related products and the company just printed blowout top-line growth and conservative guidance. The setup now offers a tradeable long with clearly defined entry, stop and …
McDonald's ($MCD) is trading near its 52-week low after a pullback that reflects macro pressure on consumer spending and slower-than-expected comps. The business still generates strong free cash flow ($7.385B), trades at ~20x EPS, and pays a healthy quarterly dividend ($1.93 / share). For patient investors, this is a long-term trade: entry at $248.…
Accenture is uniquely positioned to monetize generative AI rollouts for large enterprises. With a growing roster of AI partnerships and implementation capabilities, a measured long in ACN aims to capture a catalyst-driven re-rating tied to Anthropic deployments and services revenue expansion. Entry, targets and stop provided for a mid-term trade ho…
Puig looks mispriced to me relative to its durable brand portfolio and margin leverage. This trade idea targets recovery in global fragrance and beauty demand, better travel retail, and product cadence. Enter at $28.00, stop at $22.00, target $40.00 over a long-term horizon of 180 trading days.
Gorman-Rupp (GRC) looks set for another leg higher after a recent analyst upgrade and ongoing end-market rotation into industrials. The balance sheet and free cash flow pedigree support a constructive risk/reward for a mid-term swing trade, while rising short interest and heavier than normal volume create a potentially volatile but tradable setup.
Amerigo Resources (ARREF) has moved from bargain-bin status to a $1.03B market cap stock priced for a mid-cycle copper environment. That removes the 'deep value' narrative, but the company still offers an attractive yield, visible dividend dates, improving technicals and manageable short interest that support a long position. This is a position tra…
Blue Owl (OWL) is trading near $9.90 after a rough year for private credit and merger overhangs. The business generates >$1.3B in free cash flow and yields near 9% — metrics that argue for upside once sector fears ebb. This trade idea outlines a concrete long entry at $9.90, a stop at $8.00 and a target of $14.00 over a long-term horizon (180 tradi…
BOMXF (Bolsa Mexicana) is an OTC vehicle tied to Mexico's exchange operator that can deliver steady cash returns to patient holders. Technicals show constructive momentum near recent moving averages, but extreme short interest and shallow liquidity argue for a targeted, risk-aware position. This trade attempts to capture an attractive dividend prof…
Karman has plunged roughly 68% from its highs. The move appears overdone relative to the company's core revenue drivers and cash runway. I am upgrading to Buy with a defined entry at $8.50, a hard stop at $5.50, and primary target at $15.00 on a 180-trading-day horizon. This is a high-conviction, value-anchored trade that assumes stabilization on a…
PagerDuty is trading like a turnaround while already delivering profitability and meaningful free cash flow. At roughly $1.1 billion market cap, an improving product mix (usage-based Operations Cloud) and expanded AIOps offerings create a credible path back to mid-teens growth and multiple expansion. This trade idea lays out entry, stop, and target…
Snowline Gold's recent early ounces from the Valley area create a clearer path to financing that should dilute less and preserve upside. The market cap is $2.25B, the technicals are neutral, and short interest has been meaningful - set an entry near $11.94, a stop at $9.00 and a $16.00 target over a long-term (180 trading days) horizon.
Henry Schein has climbed off last years lows and posted a string of positive operational signals. Recent results, a new $200M efficiency program and sizeable buybacks make a mid-term long position attractive on a measured entry. The trade here is a swing trade that aims to capture a run toward prior highs while protecting capital with a tight stop…
Intesa Sanpaolo combines industry-leading operating efficiency with an attractive valuation, a 4%+ yield and a large 2026 capital return plan. We favor a buy here: entry at the market, conservative stop below recent support, target above the 52-week high. Trade horizon: medium-to-long.
First Advantage (FA) has momentum helping the stock—S&P SmallCap 600 inclusion and steady revenue growth—but the business still carries execution risk: thin profitability, meaningful leverage, and persistent investor churn. A tactical short at the current level targets a return to the $16 area over the next 45 trading days, with a stop above $22.50…
McDonald's has been sold down with the rest of the sector, but the fundamentals remain durable: $7.4B free cash flow, a 2.96% yield, high-margin franchised mix and a $20B+ delivery platform. I rate this a tactical long with concrete entry, stop and targets over a 180-trading-day horizon.
Pagaya's mixed 2026 reset is behind it: accelerating ABS sales, double‑digit revenue growth and positive free cash flow support a tactical long. Valuation is reasonable (EV/EBITDA ~7.3, P/E ~13.9), momentum is constructive, and insider buying plus raised guidance give a concrete thesis. Trade plan targets $30 with a disciplined $18 stop over a 180‑…
Netskope's product momentum and AI-facing networking improvements are beginning to show up in top-line acceleration and improving technicals. The market is fixated on quarterly cash swings and a large FY operating loss, but underneath the headline noise the company reported 28% revenue growth and delivered an earnings beat while launching NewEdge A…
